Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-11-08FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for hydroxyzine hydrochloride from Chartwell RX, LLC, authorizing a generic version under ANDA04…
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approves a supplemental application for cetirizine hydrochloride from Bionpharma Inc. This represents approval of a supplemental NDA for…
-
FDA approval · 2016-11-08FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for hydroxyzine hydrochloride (Chartwell RX, LLC), resulting in a labeling update for this generic p…
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION — Supplemental Application (APOZEAL PHARMACEUTICALS INC)
FDA approved a supplemental application for Cetirizine Hydrochloride Oral Solution from APOZEAL Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Efficacy of a Depigmented Extract of Phleum in Local Allergic Rhinitis [Phase 2]
Phase 2 trial evaluating a depigmented extract of Phleum (timothy grass) for local allergic rhinitis has completed, with efficacy results re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for cetirizine hydrochloride submitted by Rising Pharma Holdings, Inc. under an ANDA.
-
FDA approval · 2016-11-04FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
The FDA approved a supplemental application for Claritin RediTabs (loratadine) submitted by Bayer Healthcare LLC, under the existing NDA.
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)
Observed completed prospective study (Equinoxe 2) to determine the minimal clinically important difference of allergic rhinitis symptoms cau…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO4989991 in Patients With Allergic Rhinitis [Phase 1]
Phase 1 trial update of RO4989991 in patients with allergic rhinitis (also listed for asthma) has completed; the snippet does not report res…
-
FDA approval · 2016-10-31FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion, a combination product from Chattem, Inc. containing fexofenadi…
-
FDA approval · 2016-10-31FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochloride) …
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Long Term Safety Of GW685698X Via Nasal Biopsy [Phase 3]
Phase 3 trial update reporting long-term safety data for GW685698X administered via nasal biopsy in allergic rhinitis (perennial).
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Study Of Patients With Allergic Rhinitis And Asthma [Phase 4]
Phase 4 clinical trial studying patients with allergic rhinitis and asthma, sponsored by GlaxoSmithKline, has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Effect of Nasaleze on Nasal Challenge With Allergen [NA]
A clinical trial evaluating Nasaleze for allergic rhinitis was terminated; results were posted on 2016-10-27.
-
FDA approval · 2016-10-26FDA Approved: TRIAMCINOLONE ACETONIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA granted approval of a supplemental application for Triamcinolone Acetonide submitted by Sun Pharmaceutical Industries, Inc., resulting i…
-
CLINICAL_TRIALS withdrawal · 2016-10-25Clinical Trial Update: Preventing Tolerance to Oxymetazoline in Allergic Rhinitis [Phase 4]
A Phase 4 trial evaluating prevention of tolerance (tachyphylaxis) to oxymetazoline nasal decongestant in allergic rhinitis has been withdra…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies [Phase 2]
A Phase 2 trial evaluating omalizumab in combination with allergy shots for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use [NA]
The study completion update describes a pragmatic, clinic-focused trial of MedlinePlus Health Prescriptions sponsored by the University of M…
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: House Dust Mite Allergen Reduction in Bedding: Purotex Impregnated Covers of Bekaert Textiles [NA]
A completed clinical trial evaluated whether Purotex impregnated bedding covers can reduce house dust mite allergen exposure related to alle…
-
FDA approval · 2016-09-23FDA Approved: LORATADINE — Original Application (MARKSANS PHARMA LIMITED)
FDA approved loratadine via an Original Application (ANDA) for Marksans Pharma Limited, expanding access to a generic antihistamine.
-
FDA label_change · 2016-09-22FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
FDA supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray [Phase 3]
Phase 3 safety trial in children with seasonal and perennial allergic rhinitis evaluating GW685698X aqueous nasal spray versus placebo has c…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Seasonal Allergic Rhinitis In Pediatric Subjects [Phase 3]
Phase 3 pediatric trial update for seasonal and perennial allergic rhinitis sponsored by GlaxoSmithKline; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Grass Sensitisation and Allergic Rhinitis in Thai Patients
This completed clinical trial in Thai patients evaluated grass pollen sensitisation and allergic rhinitis related to weed pollens.
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Grazax Asthma Prevention [Phase 3]
Phase 3 trial evaluating Grazax for asthma prevention in allergic rhinitis patients has completed.